Latest Breaking News On - Honorary consultant nephrologist - Page 3 : comparemela.com

Existing drugs offer potential treatment for AKI

Scottish researchers uncovered that drugs used to treat angina and high blood pressure, could be used to treat AKI.

United kingdomCity ofJames leiperBritish heart foundationUniversity of edinburgh centre for cardiovascular scienceUniversity of edinburghScience translational medicineBean dhaunSenior clinical lecturerHonorary consultant nephrologistCardiovascular scienceAssociate medical director

Potential Treatment for Kidney Disease Found in Drug Discovery

Potential Treatment for Kidney Disease Found in Drug Discovery
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofJames leiperBritish heart foundationUniversity of edinburgh centre for cardiovascular scienceResearch councilUniversity of edinburghScience translationalMedical research councilBritish heartBean dhaunSenior clinical lecturerHonorary consultant nephrologistCardiovascular scienceAssociate medical director

Drug discovery offers potential treatment for common kidney disease

A serious condition that can cause the kidneys to suddenly stop working could be treated with existing medicines, a new study shows.

United kingdomCity ofJames leiperBritish heart foundationUniversity of edinburgh centre for cardiovascular scienceResearch councilUniversity of edinburghScience translationalMedical research councilBritish heartBean dhaunSenior clinical lecturerHonorary consultant nephrologistCardiovascular scienceAssociate medical directorCute kidney injury inflammation endothelin

Bayer receives acceptance of Kerendia® ▼ (finerenone) by Scottish Medicines Consortium (SMC) for treating adult patients with chronic kidney disease associated with type 2 diabetes in NHS Scotland

Bayer announced that Kerendia® (finerenone) (10mg and 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) antagonist,2 has been accepted for use within NHS Scotland by The Scottish Medicines Consortium (SMC) for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria)

United kingdomNorth berwickEast lothianAlison railtonPatrick markGemma currieKevin fernandoSchool of cardiovascular metabolic healthQueen elizabeth university hospitalScottish lead primary care diabetes societyGp partner north berwick health centreUniversity of glasgowKidney research united kingdomScottish medicines consortiumHonorary consultant nephrologistNorth berwick health centre

Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs placebo in people with chronic kidney disease

Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs placebo in people with chronic kidney disease
q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.

United statesRichard haynesWilliam herringtonCarinne brouillonEli lillyJeff emmickUniversity of oxfordOxford population healthBoehringer ingelheimResearch council population health unitLilly allianceProduct developmentAmerican society of nephrologyAmerican societyKidney weekNew england journal